Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L13a pseudogene 27 (RPL13AP27) is a processed pseudogene in the human genome, designated as a non-functional, non-protein-coding copy derived from the functional RPL13A gene, which encodes a structural component of the large 60S ribosomal subunit[1][2][8]. Like other pseudogenes, RPL13AP27 does not encode a functional protein and is not known to have any physiological roles, although pseudogenes in general can sometimes exert regulatory effects at the RNA level[5]. It is annotated at the genomic level and has no direct relevance as a drug target, biomarker, or disease gene on its own.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L13a pseudogene 27 (RPL13AP27).